Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Themis Bioscience
Themis Bioscience
Merck, via its Themis buy, to move first COVID-19 vaccine into clinical development in Q3
Fierce Biotech
Fri, 07/31/20 - 11:02 am
Merck
COVID-19
Themis Bioscience
V591
Merck teams up with Themis to develop vaccines
Fierce Biotech
Thu, 08/22/19 - 11:09 am
Merck
vaccines
Themis Bioscience
R&D
Themis pulls out of IPO, looks into 'strategic options' to fund phase 3 vaccine trial
Fierce Biotech
Fri, 11/9/18 - 11:52 am
Themis Bioscience
IPOs
Amsterdam
chikungunya virus